Rating Change
RBC Capital reiterated its Outperform rating on Biogen Inc. (NASDAQ:BIIB) on October 08, 2026.
reiterateNASDAQ:BIIB
RBC Capital Reiterates Outperform Rating on Biogen Inc. (BIIB)
RBC Capital reiterated its Outperform rating on Biogen Inc. (NASDAQ:BIIB) on October 08, 2026.
At publication ·
What changed
Biogen Inc. (NASDAQ:BIIB) · reiterate
- Firm
- RBC Capital
- Rating
- Outperform to Outperform
- Price at event
- $218.43
- Market capitalization
- $25.3B
At a glance
Key takeaways
- RBC Capital reiterated an Outperform rating on Biogen Inc. (BIIB) on October 8, 2026, with the stock trading at $218.43.
Market Context
Biogen Inc. operates in the Healthcare sector. The stock currently trades at $218.43 with a market capitalization of $25.3B. The stock has gained 24.9% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Biogen Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Biogen Inc.
Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 08, 2026 | RBC Capital | Outperform | N/A |
| Sep 10, 2026 | HSBC | Reduce | N/A |
| Sep 03, 2026 | Piper Sandler | Overweight | N/A |
| Aug 25, 2026 | RBC Capital | Outperform | N/A |
| Aug 13, 2026 | Wolfe Research | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View BIIB Stock Page
Frequently Asked Questions
What does the Outperform rating mean for BIIB?
A rating of Outperform from RBC Capital reflects the analyst's outlook on Biogen Inc. (NASDAQ:BIIB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BIIB forecast page.